Kite and HiFiBiO Therapeutics Announce a Research Collaboration to Develop Technology for the Potential Discovery of Neoantigen-Reactive T Cell Receptors (TCRs) for the Treatment of Cancer

Life Science

CANbridge Files to Start Clinical Trials of Breast Cancer Drug in China

Life Science

Johnson & Johnson Completes Divestiture of LifeScan to Platinum Equity

Life Science

Five Prime Therapeutics and Zai Lab Dosed First Patient in Phase 3, Global Registrational Trial of Bemarituzumab in Front-Line Advanced Gastric and Gastroesophageal Junction Cancers

Life Science

Crop Announces Major Expansion in Italy

Cannabis, Life Science

Dragonfly and Merck Strike $695 Million Deal for Solid Tumors

Life Science

Innovent Approved to Start US Clinical Trial of CD47 Immunotherapy

Life Science

Fosun Pharma Officially Announces Plan for Henlius IPO in Hong Kong

Life Science

Adlai Nortye Opens New US Headquarters, Solidifying its Position in the Global Pharma Industry

Life Science

Pfizer Snags FDA Approval for New Lung Cancer Drug Vizimpro

Life Science

Agilent to Expand Portfolio and Capabilities in Cell Analysis with Acquisition of ACEA Biosciences

Life Science

Cellular Bio to Manufacture Novartis CAR-T Drug in China in $40 Million Deal

Life Science

F-Prime, Atlas lead cancer startup Akrevia to $30M A round

Life Science

Aphria closes deal, now worth up to $300 million, to acquire Scythian’s Latin American assets

Cannabis, Life Science

Lilly Licenses Chugai Pharma’s Oral Diabetes Drug for $50 Million Upfront

Life Science